WealthPLAN Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-400
Closed -$21.6K 1036
2023
Q2
$21.6K Hold
400
﹤0.01% 662
2023
Q1
$21.8K Buy
+400
New +$19.5K ﹤0.01% 708
2017
Q2
Sell
-807
Closed -$36.5K 384
2017
Q1
$36.5K Buy
+807
New +$34.2K 0.13% 138
2016
Q3
$47.1K Sell
1,227
-1,227
-50% -$49.2K 0.02% 346
2016
Q2
$51.4K Buy
+2,454
New +$101K 0.01% 912
2015
Q4
$20.3K Buy
+477
New +$21.9K ﹤0.01% 909
2015
Q2
Sell
-100
Closed -$5K 498
2015
Q1
$5K Buy
+100
New +$4.78K ﹤0.01% 423

Other funds holding SNY

WealthPLAN Partners's SNY Position: Q3 2023 in Review

WealthPLAN Partners sold out of Sanofi (SNY) in Q3 2023, closing a stake of 400 shares — an estimated $21.6K sold.

WealthPLAN Partners first reported a position in SNY in Q1 2015 and held it in 7 quarters. The position peaked at $51.4K in Q2 2016. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

  • WealthPLAN Partners reported no remaining Sanofi position as of Q3 2023 after selling out during the quarter.
  • WealthPLAN Partners sold 400 Sanofi shares in Q3 2023, an estimated $21.6K.
  • WealthPLAN Partners first reported a position in Sanofi in Q1 2015 and held it in 7 quarters.
  • WealthPLAN Partners's Sanofi position peaked at $51.4K in Q2 2016.
  • 696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on WealthPLAN Partners's 13F filing for Q3 2023, filed 2 Nov 2023.